VIDAS Lyme IgM II (LYM), REF 416436
FDA Recall Z-0436-2022 · Posted None
Advertisement
Recalling FirmbioMerieux, Inc.
Recall StatusOpen, Classified
Product CodeLSR
Date Initiated2021-09-22
Product QuantityThree lots
Reason for Recall
bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.
Firm Action
For products with No remaining shelf life (taking into account the revised expiration date):
- Identify impacted lots
- Stop using the listed impacted lots
- Destroy the remaining impacted lots in your inventory
For products with remaining shelf life (taking into account the revised expiration date):
- Identify impacted products and lots listed
- Update product expiration date per your internal procedures of the remaining usable lots to meet the new revised expiration date specified in Table 1
- Continue product use until the revised expiration date.
Consignees are asked to distribute this information to all appropriate personnel in their laboratory, retain a copy in their files, and forward this information to all parties that may use this product, including others to whom you may have transferred affected product.
Complete the Acknowledgement Form in Attachment A and return it to [email protected] or Fax to: (919) 620-3306 to confirm receipt of this notice.
Root Cause
Nonconforming Material/Component
Distribution Pattern
US Nationwide distribution.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement